18-06-2023 15:01 via finanznachrichten.de

21st Austria weekly - DO&CO, Marinomed (15/06/2023)

Marinomed: Marinomed Biotech AG announced the introduction of a new Carragelose eye drop product (MAM-1001-3), expanding the range of the marketed Carragelose OTC portfolio. The product has a valid...
Weiterlesen »